Letters

More on switching statins: Comments from Pfizer

BMJ 2006; 333 doi: https://doi.org/10.1136/bmj.333.7569.655 (Published 21 September 2006) Cite this as: BMJ 2006;333:655
  1. Kate Lloyd, medical director (Kate.Lloyd@Pfizer.com)
  1. Pfizer, Tadworth, Surrey KT20 7NS

    EDITOR—Moon and Bogle claim that all statins are the same except for the cost.1 NHS costs need to be managed but should not be the sole driver of clinical decision making.


    Embedded Image

    New guidelines recommend that cholesterol < 4 mmol/l is the optimal target for patients with cardiovascular disease, diabetes, or high risk primary prevention.2 Data modelled from the CURVES …

    View Full Text

    Sign in

    Log in through your institution

    Free trial

    Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
    Sign up for a free trial

    Subscribe